LEWIS JOEL bought GALT
September 12, 2025 · Form 4 insider transaction
LEWIS JOEL bought 14,000 shares of Galectin Therapeutics Inc. at $2.39 per share, a transaction worth $33.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,000
Price
$2.39
Total value
$33.5K
InsiderLEWIS JOEL
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 12, 2025
Filing dateSeptember 15, 2025
Shares owned after846,592
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.